Literature DB >> 34379494

Profiling Human Cytomegalovirus-Specific T Cell Responses Reveals Novel Immunogenic Open Reading Frames.

Rekha Dhanwani1, Sandeep Kumar Dhanda1, John Pham1, Gregory P Williams1, John Sidney1, Alba Grifoni1, Gaelle Picarda1,2, Cecilia S Lindestam Arlehamn1, Alessandro Sette1,3, Chris A Benedict1,2.   

Abstract

Despite the prevalence and medical significance of human cytomegalovirus (HCMV) infections, a systematic analysis of the targets of T cell recognition in humans that spans the entire genome and includes recently described potential novel open reading frames (ORFs) is not available. Here, we screened a library of epitopes predicted to bind HLA class II that spans over 350 different HCMV ORFs and includes ∼150 previously described and ∼200 recently described potential novel ORFs by using an ex vivo gamma interferon (IFN-γ) FluoroSpot assay. We identified 235 unique HCMV-specific epitopes derived from 100 ORFs, some previously described as immunodominant and others that were not previously described to be immunogenic. Of those, 41 belong to the set of recently reported novel ORFs, thus providing evidence that at least some of these are actually expressed in vivo in humans. These data reveal that the breadth of the human T cell response to HCMV is much greater than previously thought. The ORFs and epitopes identified will help elucidate how T cell immunity relates to HCMV pathogenesis and instruct ongoing HCMV vaccine research. IMPORTANCE To understand the crucial role of adaptive immunity in controlling cytomegalovirus infection and disease, we systematically analyzed the CMV "ORFeome" to identify new CMV epitopes targeted primarily by CD4 T cells in humans. Our study identified >200 new T cell epitopes derived from both canonical and novel ORFs, highlighting the substantial breadth of the anti-CMV T cell response and providing new targets for vaccine design.

Entities:  

Keywords:  T cells; adaptive immunity; cytomegalovirus; epitope; human herpesviruses; immune response; infectious disease

Mesh:

Substances:

Year:  2021        PMID: 34379494      PMCID: PMC8513490          DOI: 10.1128/JVI.00940-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  72 in total

1.  Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals.

Authors:  Florian Kern; Torsten Bunde; Nicole Faulhaber; Felix Kiecker; Elham Khatamzas; Ina-Maria Rudawski; Axel Pruss; Jan-Willem Gratama; Rudolf Volkmer-Engert; Ralf Ewert; Petra Reinke; Hans-Dieter Volk; Louis J Picker
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

2.  Maternal human immunodeficiency virus infection and congenital transmission of cytomegalovirus.

Authors:  Elaine L Duryea; Pablo J Sánchez; Jeanne S Sheffield; Gregory L Jackson; George D Wendel; Barbara S McElwee; Linda F Boney; Mary M Mallory; Kristine E Owen; Elizabeth K Stehel
Journal:  Pediatr Infect Dis J       Date:  2010-10       Impact factor: 2.129

Review 3.  Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy.

Authors:  Céline M Laumont; Claude Perreault
Journal:  Cell Mol Life Sci       Date:  2017-08-19       Impact factor: 9.261

4.  Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients.

Authors:  G V Quinnan; N Kirmani; A H Rook; J F Manischewitz; L Jackson; G Moreschi; G W Santos; R Saral; W H Burns
Journal:  N Engl J Med       Date:  1982-07-01       Impact factor: 91.245

5.  The immune epitope database: a historical retrospective of the first decade.

Authors:  Nima Salimi; Ward Fleri; Bjoern Peters; Alessandro Sette
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

6.  Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

Authors:  R J Whitley; G Cloud; W Gruber; G A Storch; G J Demmler; R F Jacobs; W Dankner; S A Spector; S Starr; R F Pass; S Stagno; W J Britt; C Alford; S Soong; X J Zhou; L Sherrill; J M FitzGerald; J P Sommadossi
Journal:  J Infect Dis       Date:  1997-05       Impact factor: 5.226

7.  Cytomegalovirus-Specific CD4 T Cells Are Cytolytic and Mediate Vaccine Protection.

Authors:  Shilpi Verma; Daniela Weiskopf; Ankan Gupta; Bryan McDonald; Bjoern Peters; Alessandro Sette; Chris A Benedict
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

8.  A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans.

Authors:  Cecilia S Lindestam Arlehamn; Denise M McKinney; Chelsea Carpenter; Sinu Paul; Virginie Rozot; Edward Makgotlho; Yolande Gregg; Michele van Rooyen; Joel D Ernst; Mark Hatherill; Willem A Hanekom; Bjoern Peters; Thomas J Scriba; Alessandro Sette
Journal:  PLoS Pathog       Date:  2016-07-13       Impact factor: 6.823

Review 9.  Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation.

Authors:  Donna Collins-McMillen; Jason Buehler; Megan Peppenelli; Felicia Goodrum
Journal:  Viruses       Date:  2018-08-20       Impact factor: 5.048

Review 10.  CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies.

Authors:  Corinne J Smith; Michael Quinn; Christopher M Snyder
Journal:  Front Immunol       Date:  2016-09-15       Impact factor: 7.561

View more
  3 in total

1.  Immunological memory to common cold coronaviruses assessed longitudinally over a three-year period pre-COVID19 pandemic.

Authors:  Esther Dawen Yu; Tara M Narowski; Eric Wang; Emily Garrigan; Jose Mateus; April Frazier; Daniela Weiskopf; Alba Grifoni; Lakshmanane Premkumar; Ricardo da Silva Antunes; Alessandro Sette
Journal:  Cell Host Microbe       Date:  2022-07-20       Impact factor: 31.316

2.  Immunological memory to Common Cold Coronaviruses assessed longitudinally over a three-year period.

Authors:  Esther Dawen Yu; Tara M Narowski; Eric Wang; Emily Garrigan; Jose Mateus; April Frazier; Daniela Weiskopf; Alba Grifoni; Lakshmanane Premkumar; Ricardo da Silva Antunes; Alessandro Sette
Journal:  bioRxiv       Date:  2022-03-02

3.  Harnessing anti-cytomegalovirus immunity for local immunotherapy against solid tumors.

Authors:  Nicolas Çuburu; Lukasz Bialkowski; Sergio M Pontejo; Shiv K Sethi; Alexander T F Bell; Rina Kim; Cynthia D Thompson; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-24       Impact factor: 12.779

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.